Impact of molecular subtypes on the prediction of distant recurrence in estrogenreceptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrinetherapy
Mark Laible et al. (2019)
BMC Cancer (2019) 19:694
Biobanking from the patient perspective
Mitchell et al. (2015)
Research Involvement and Engagement (2015) 1:4